IDiyas

For the Inventor, By the Inventor

Tucson, AZ, United States of America

Jacques Mauger

USPTO Granted Patents = 15 

 

Average Co-Inventor Count = 5.4

ph-index = 3

Forward Citations = 33(Granted Patents)


Location History:

  • Paris, FR (2002 - 2007)
  • Tuscon, AZ (US) (2013)
  • Tucson, AZ (US) (2006 - 2017)
  • Oro Valley, AZ (US) (2014 - 2018)
  • Bridgewater, NJ (US) (2018)

Company Filing History:

goldMedal7 out of 377 
 
Aventis Pharma S.a.
 patents
silverMedal5 out of 1,451 
 
Sanofi
 patents
bronzeMedal3 out of 389 
 
Sanofi-aventis
 patents
4. 2 out of 576 
 
The Salk Institute for Biological Studies
 patents
where one patent can have more than one assignee

Years Active: 2002-2018

Loading Chart...
Loading Chart...
15 patents (USPTO):
1. 10138235 - Pyrazolopyridine derivatives, preparation process therefor and therapeutic use thereof (2018-11-27),
2. 9957294 - Compositions and methods for analyzing histidine phosphorylation (2018-05-01),
3. 9850319 - Generation and use of polyclonal and monoclonal antibodies specific for 3-phosphohistidine (2017-12-26),
4. 8791133 - Pyridylvinylpyrazoloquinolines as PAR1 inhibitors (2014-07-29),
5. 8420824 - Substituted pyrazoles, compositions containing these, method of production and use (2013-04-16),
6. 8410286 - Substituted pyrazoles, compositions containing these, method of production and use (2013-04-02),
7. 8163768 - 1,4-dihydropyridine-fused heterocycles, process for preparing the same, use and compositions containing them (2012-04-24),
8. 7989439 - Substituted pyrazoles, compositions containing these, method of production and use (2011-08-02),
9. 7825115 - Cyclic urea compounds, preparation thereof and pharmaceutical use thereof as kinase inhibitors (2010-11-02),
10. 7354933 - Cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors (2008-04-08),
11. 7279480 - Hexahydropyridazine-3-carboxylic acid hydrazide and hydrazone derivatives, combinatorial libraries containing same, pharmaceutical compositions containing same and methods of preparation (2007-10-09),
12. 7223758 - Pyridazine derivative, pharmaceutical composition thereof, its pharmaceutical use, and process for its preparation (2007-05-29),
13. 7034022 - Hexahydropyridazine-3-carboxylic acid derivatives, pharmaceutical compositions containing same and methods of preparation (2006-04-25),
14. 6566542 - 17-Halogenated 19-nor steroids, preparation process and intermediates, use as medicaments and the pharmaceutical compositions containing them (2003-05-20),
15. 6423700 - 17-halogenated 19-nor steroids, method and intermediates for preparing same, use as medicines and pharmaceutical compositions containing same (2002-07-23),

Title: Innovations and Contributions of Inventor Jacques Mauger

Introduction

Jacques Mauger is a prominent inventor based in Tucson, AZ (US), known for his significant contributions to the field of pharmaceuticals and biochemistry. With a total of 15 patents to his name, Mauger has made remarkable advancements in therapeutic applications and analytical methods.

Latest Patents

Among his latest patents is the invention of pyrazolopyridine derivatives, which includes a preparation process and therapeutic uses. This invention focuses on FGF-inhibiting pyrazolopyrimidine derivatives of a specific general formula, providing a new avenue for therapeutic interventions. Another notable patent involves compositions and methods for analyzing histidine phosphorylation. This patent discloses a peptide structure that can be utilized to produce sequence-independent anti-phosphohistidine antibodies, enhancing the understanding of phosphorylation in biological systems.

Career Highlights

Throughout his career, Jacques Mauger has worked with leading pharmaceutical companies, including Aventis Pharma S.A. and Sanofi. His work in these organizations has allowed him to develop innovative solutions that address critical health challenges.

Collaborations

Mauger has collaborated with notable professionals in his field, including Anil Nair and Marcel Patek. These collaborations have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Jacques Mauger's contributions to the field of invention and innovation are significant, particularly in the areas of pharmaceuticals and biochemistry. His patents reflect a commitment to advancing therapeutic methods and analytical techniques, showcasing his impact on the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…